MEP16708A - Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors - Google Patents

Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors

Info

Publication number
MEP16708A
MEP16708A MEP-167/08A MEP16708A MEP16708A ME P16708 A MEP16708 A ME P16708A ME P16708 A MEP16708 A ME P16708A ME P16708 A MEP16708 A ME P16708A
Authority
ME
Montenegro
Prior art keywords
beta
preparation
amyloid peptide
same
peptide production
Prior art date
Application number
MEP-167/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Pierre Despeyroux
Daniel Frehel
Bruno Schoentjes
Dorsselaer Viviane Van
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MEP16708A publication Critical patent/MEP16708A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MEP-167/08A 2003-01-23 2004-01-22 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors MEP16708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300703A FR2850380B1 (fr) 2003-01-23 2003-01-23 Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
PCT/FR2004/000140 WO2004067520A1 (fr) 2003-01-23 2004-01-22 Derives d'acylaminothiazole, leur preparation et leur utilisation en tant qu’inhibiteurs de la production du peptide beta-amyloide

Publications (1)

Publication Number Publication Date
MEP16708A true MEP16708A (en) 2010-06-10

Family

ID=32669150

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-167/08A MEP16708A (en) 2003-01-23 2004-01-22 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors

Country Status (24)

Country Link
US (2) US7563903B2 (xx)
EP (1) EP1590337B1 (xx)
JP (1) JP2006515888A (xx)
KR (1) KR101059669B1 (xx)
CN (1) CN100532370C (xx)
AR (1) AR042745A1 (xx)
AT (1) ATE404545T1 (xx)
AU (1) AU2004207658B2 (xx)
BR (1) BRPI0406893A (xx)
CA (1) CA2511610A1 (xx)
DE (1) DE602004015726D1 (xx)
FR (1) FR2850380B1 (xx)
HR (1) HRP20050637A2 (xx)
IL (1) IL169428A (xx)
MA (1) MA27610A1 (xx)
ME (1) MEP16708A (xx)
MX (1) MXPA05007847A (xx)
NO (1) NO330415B1 (xx)
NZ (1) NZ541147A (xx)
PL (1) PL377999A1 (xx)
RS (1) RS51168B (xx)
RU (1) RU2360907C2 (xx)
TW (1) TWI320710B (xx)
WO (1) WO2004067520A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009344A2 (en) * 2003-06-05 2005-02-03 Elan Pharmaceuticals, Inc. Acylated amino acid amidyl pyrazoles and related compounds
AU2007207743B2 (en) * 2006-01-18 2010-07-08 Amgen Inc. Thiazole compounds as protein kinase B (PKB) inhibitors
CA2692713A1 (en) 2007-07-17 2009-01-22 Amgen Inc. Heterocyclic modulators of pkb
WO2009011871A2 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
EP2371421A1 (en) * 2010-03-04 2011-10-05 Université de Lille 2 Droit et Santé Ligands of insulin degrading enzyme and their uses
EP2508511A1 (en) * 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
CN103145692B (zh) * 2013-03-12 2014-07-16 盐城工学院 一种4,5-二氢-6H-环戊烷并[b]噻吩-6-酮的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069075A (ko) * 1996-11-22 2000-11-25 진 엠. 듀발 Ｎ-(아릴/헤테로아릴/알킬아세틸)아미노산 아미드, 이들을 함유하는 제약 조성물, 및 이들 화합물을 사용하여 베타-아밀로이드 펩티드의 방출 및(또는) 합성의 억제 방법
ES2319239T3 (es) * 1996-12-23 2009-05-05 Elan Pharmaceuticals, Inc. Cicloalquilo, lactama, lactona y compuestos relacionados, composiciones farmaceuticas que comprenden los mismos y procedimientos para inhibir la liberacion del peptido beta-amiloide y/o sintesis mediante el uso de tales compuestos.
ES2237919T4 (es) * 1998-06-18 2007-05-01 Bristol-Myers Squibb Company Inhibidores aminotiazol sustituidos con carbono de quinasas dependientes de ciclina.
AU6229699A (en) * 1998-10-26 2000-05-15 Sumitomo Pharmaceuticals Company, Limited Beta-amyloid formation inhibitors
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
AR039059A1 (es) * 2001-08-06 2005-02-09 Sanofi Aventis Compuesto derivado de acilaminotiazol, su utilizacion, procedimientos para prepararlo, composicion farmaceutica que lo comprende, y compuestos intermediarios

Also Published As

Publication number Publication date
CA2511610A1 (en) 2004-08-12
NO330415B1 (no) 2011-04-11
IL169428A (en) 2010-12-30
BRPI0406893A (pt) 2006-01-03
MA27610A1 (fr) 2005-11-01
FR2850380A1 (fr) 2004-07-30
RS20050563A (xx) 2007-06-04
EP1590337A1 (fr) 2005-11-02
PL377999A1 (pl) 2006-02-20
TWI320710B (en) 2010-02-21
EP1590337B1 (fr) 2008-08-13
MXPA05007847A (es) 2006-05-17
WO2004067520A1 (fr) 2004-08-12
DE602004015726D1 (de) 2008-09-25
AU2004207658B2 (en) 2009-10-29
JP2006515888A (ja) 2006-06-08
NZ541147A (en) 2008-06-30
RU2360907C2 (ru) 2009-07-10
KR101059669B1 (ko) 2011-08-25
AU2004207658A1 (en) 2004-08-12
FR2850380B1 (fr) 2006-07-07
HRP20050637A2 (en) 2005-10-31
TW200503699A (en) 2005-02-01
KR20050094039A (ko) 2005-09-26
US7879889B2 (en) 2011-02-01
CN100532370C (zh) 2009-08-26
AR042745A1 (es) 2005-06-29
US20060052426A1 (en) 2006-03-09
RS51168B (sr) 2010-10-31
US7563903B2 (en) 2009-07-21
NO20053588D0 (no) 2005-07-22
NO20053588L (no) 2005-09-22
ATE404545T1 (de) 2008-08-15
RU2005126608A (ru) 2006-04-27
CN1777593A (zh) 2006-05-24
US20090253753A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
ME00159B (me) DERIVATI HINOLINA l IZOHINOLINA, POSTUPAK ZA NJIHOVO DOBIJANJE l NJIHOVA PRIMENA KAO SUPRESORA ZAPALJENJA
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
RS52534B (en) MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
MEP58808A (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
HRP20050359B1 (hr) Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
NO20085317L (no) Imidazoazepinonforbindelser
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
TNSN05277A1 (en) Novel bioisosteres of actinonin
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
MEP16708A (en) Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
TW200624429A (en) Novel cysteine protease inhibitors